Plante Moran Financial Advisors’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-10,067
Closed -$287K 869
2020
Q1
$287K Sell
10,067
-1,333
-12% -$51.8K 0.13% 91
2019
Q4
$472K Buy
11,400
+8,067
+242% +$177K 0.16% 86
2019
Q3
$47K Buy
+3,333
New +$69.8K 0.01% 350

Other funds holding VBIV

Plante Moran Financial Advisors's VBIV Position: Q2 2020 in Review

Plante Moran Financial Advisors sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q2 2020, closing a stake of 10,067 shares — an estimated $287K sold.

Plante Moran Financial Advisors first reported a position in VBIV in Q3 2019 and held it in 3 quarters. The position peaked at $472K in Q4 2019. 102 funds tracked by Wall St. Rank hold VBIV as of Q2 2020.

  • Plante Moran Financial Advisors reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q2 2020 after selling out during the quarter.
  • Plante Moran Financial Advisors sold 10,067 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q2 2020, an estimated $287K.
  • Plante Moran Financial Advisors first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q3 2019 and held it in 3 quarters.
  • Plante Moran Financial Advisors's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $472K in Q4 2019.
  • 102 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q2 2020.

Based on Plante Moran Financial Advisors's 13F filing for Q2 2020, filed 10 Aug 2020.